Cannabidiol (CBD) oil : rehashing the research, roles and regulations in Australia

Justin Sinclair; Camilla Adams; Greta-Rose Thurgood; Maggie Davidson; Mike Armour; Jerome Sarris

doi:10.33235/ajhnm.32.2.54-60

Cannabidiol (CBD) oil : rehashing the research, roles and regulations in Australia

Justin Sinclair
, Camilla Adams
, Greta-Rose Thurgood
, Maggie Davidson
, Mike Armour
, Jerome Sarris

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

Abstract

The use of medicinal cannabis and cannabidiol (CBD) oil internationally is continuing to propagate, with the CBD market blazing a path to an estimated value of US$23.7 billion by 2023. This, coupled with the promises of its therapeutic potential regularly doing the rounds on social media, it is not surprising that there are increasing numbers of Australian patients and practitioners that are wanting to learn more and obtain access. This commentary shares a brief overview of CBD's chemistry, pharmacology, therapeutic uses, workplace health and safety implications, potential side effects, drug driving laws and drug interactions, along with the current regulatory and legal framework for its therapeutic use in Australia.

Original language	English
Pages (from-to)	54-60
Number of pages	7
Journal	Australian Journal of Herbal And Naturopathic Medicine
Volume	32
Issue number	2
DOIs	https://doi.org/10.33235/ajhnm.32.2.54-60
Publication status	Published - Jun 2020

Bibliographical note

Publisher Copyright:
© NHAA 2020.

Keywords

Australia
cannabis
therapeutics

Access to Document

10.33235/ajhnm.32.2.54-60

Cite this

@article{79483a7c7070476cb4a1b435406ebf6d,

title = "Cannabidiol (CBD) oil : rehashing the research, roles and regulations in Australia",

abstract = "The use of medicinal cannabis and cannabidiol (CBD) oil internationally is continuing to propagate, with the CBD market blazing a path to an estimated value of US\$23.7 billion by 2023. This, coupled with the promises of its therapeutic potential regularly doing the rounds on social media, it is not surprising that there are increasing numbers of Australian patients and practitioners that are wanting to learn more and obtain access. This commentary shares a brief overview of CBD's chemistry, pharmacology, therapeutic uses, workplace health and safety implications, potential side effects, drug driving laws and drug interactions, along with the current regulatory and legal framework for its therapeutic use in Australia.",

keywords = "Australia, cannabis, therapeutics",

author = "Justin Sinclair and Camilla Adams and Greta-Rose Thurgood and Maggie Davidson and Mike Armour and Jerome Sarris",

note = "Publisher Copyright: {\textcopyright} NHAA 2020.",

year = "2020",

month = jun,

doi = "10.33235/ajhnm.32.2.54-60",

language = "English",

volume = "32",

pages = "54--60",

journal = "Australian Journal of Herbal And Naturopathic Medicine",

issn = "2209-119X",

publisher = "Naturopaths and Herbalists Association of Australia",

number = "2",

}

TY - JOUR

T1 - Cannabidiol (CBD) oil : rehashing the research, roles and regulations in Australia

AU - Sinclair, Justin

AU - Adams, Camilla

AU - Thurgood, Greta-Rose

AU - Davidson, Maggie

AU - Armour, Mike

AU - Sarris, Jerome

N1 - Publisher Copyright: © NHAA 2020.

PY - 2020/6

Y1 - 2020/6

N2 - The use of medicinal cannabis and cannabidiol (CBD) oil internationally is continuing to propagate, with the CBD market blazing a path to an estimated value of US$23.7 billion by 2023. This, coupled with the promises of its therapeutic potential regularly doing the rounds on social media, it is not surprising that there are increasing numbers of Australian patients and practitioners that are wanting to learn more and obtain access. This commentary shares a brief overview of CBD's chemistry, pharmacology, therapeutic uses, workplace health and safety implications, potential side effects, drug driving laws and drug interactions, along with the current regulatory and legal framework for its therapeutic use in Australia.

AB - The use of medicinal cannabis and cannabidiol (CBD) oil internationally is continuing to propagate, with the CBD market blazing a path to an estimated value of US$23.7 billion by 2023. This, coupled with the promises of its therapeutic potential regularly doing the rounds on social media, it is not surprising that there are increasing numbers of Australian patients and practitioners that are wanting to learn more and obtain access. This commentary shares a brief overview of CBD's chemistry, pharmacology, therapeutic uses, workplace health and safety implications, potential side effects, drug driving laws and drug interactions, along with the current regulatory and legal framework for its therapeutic use in Australia.

KW - Australia

KW - cannabis

KW - therapeutics

UR - http://hdl.handle.net/1959.7/uws:56558

UR - https://search-informit-com-au.ezproxy.uws.edu.au/fullText;dn=218546138513880;res=IELHEA

U2 - 10.33235/ajhnm.32.2.54-60

DO - 10.33235/ajhnm.32.2.54-60

M3 - Article

SN - 2209-119X

VL - 32

SP - 54

EP - 60

JO - Australian Journal of Herbal And Naturopathic Medicine

JF - Australian Journal of Herbal And Naturopathic Medicine

IS - 2

ER -

Cannabidiol (CBD) oil : rehashing the research, roles and regulations in Australia

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this